TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of mycobacterial ...

Researchers have found that approved drugs that were originally shown to normalize blood vessels surrounding tumors (to improve drug delivery to cancer cells) can enhance the delivery of ...

University of Dundee researchers have made a significant breakthrough in the global effort to combat tuberculosis.

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...

A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George's, University of ...

An international research team headed by scientists at the University of British Columbia has demonstrated how a novel semi-synthetic compound derived from sanguinarine (SG), an alkaloid extracted ...

IPC to develop IP Reference Standards for anti-TB medicine bedaquiline: Shardul Nautiyal, Mumbai Thursday, January 22, 2026, 08:00 Hrs [IST] In order to ensure quality and safe an ...

LONDON, Aug. 24, 2020 /PRNewswire/ -- Forecasts & Analysis of Epidemiology by Regions (United States, Europe, Germany, France, Italy, Spain, UK, Japan & Rest of the World), by Regional Markets (North ...

BOSTON – Tuberculosis (TB) is often overlooked in developed countries such as the United States, but this bacterial infection remains one of the deadliest diseases globally and results in millions of ...